The biocatalytic
toolbox has recently been expanded to include
enzyme-catalyzed carbene transfer reactions not occurring in Nature.
Herein, we report the development of a biocatalytic strategy for the
synthesis of enantioenriched α-trifluoromethyl amines through
an asymmetric N–H carbene insertion reaction catalyzed by engineered
variants of cytochrome
c
552
from
Hydrogenobacter thermophilus
. Using a combination of protein and substrate engineering, this
metalloprotein scaffold was redesigned to enable the synthesis of
chiral α-trifluoromethyl amino esters with up to >99% yield
and 95:5 er using benzyl 2-diazotrifluoropropanoate as the carbene
donor. When the diazo reagent was varied, the enantioselectivity of
the enzyme could be inverted to produce the opposite enantiomers of
these products with up to 99.5:0.5 er. This methodology is applicable
to a broad range of aryl amine substrates, and it can be leveraged
to obtain chemoenzymatic access to enantioenriched β-trifluoromethyl-β-amino
alcohols and halides. Computational analyses provide insights into
the interplay of protein- and reagent-mediated control on the enantioselectivity
of this reaction. This work introduces the first example of a biocatalytic
N–H carbenoid insertion with an acceptor–acceptor carbene
donor, and it offers a biocatalytic solution for the enantioselective
synthesis of α-trifluoromethylated amines as valuable synthons
for medicinal chemistry and the synthesis of bioactive molecules.